There is hype and there is reality. For this to really take off, GOHE needs to show evidence that cannabis marketplace is accepting their new "M-Coin". If it gains traction, that would be huge...but that is a tremendously BIG "IF".

Their next announcement needs to be we have established X companies, including Y and Z, who have agreed that they will accept and welcome payment with M-Token for cannabis and cannabis-related products.

Got it! And agree. M Token announcement this AM will be interesting to see if it gives them "legs". Let's see if they really have it all together for delivery in Q1.

That makes no sense. They may indeed (and likely) end up doing a reverse split at some point, but certainly don't need to drive the price any lower to do so. How about they actually make some REVENUE before they do anything else. Sheeze, these folks are big on partnerships and promises but so far nowhere on revenue and execution!

Ultimately, us as individual investors are the "idiots" I guess. I figure Jenkins probably joined the BOD for Archer just because he is friends with Mullan. Who knows, maybe so he can write-off a vacation to the Sarasota area. Again, as I have said many times of this board, worth keeping an eye on where Mullan/Jenkins land ultimately in terms of anything that attempts to leverage anatabine even in an ancillary way. Perhaps they are "guiltless" with respect to RCPI failures, but IMO, they made some very questionable decisions in terms of driving the company into the ground.

...and when is GOHE going to have something to report that is really banking/technology-related? That is supposed to be their real value. What they release instead is something that sounds like not much more than an advertising circlular that perhaps they make a few pennies on...

Thanks for your willingness to do so, Nep!

The problem we have is Mullan and Jenkins are the ones that could provide insight into the pros/cons of the value of the IP. And, of course, they are scared to death to offer any insight because it could potentially implicate them as to their incompetence in running the company into the ground.

The newly announced CEO of GOHE's MoneyTrac subsidiary was a paralegal not too long ago. Not saying she won't be good and has not earned her stripes, but her background not necessarily in financial markets. Maybe she's got great connections in the world of cannabis.

Not necessarily sure about that...doubt it's going to go from 235K to $40M (I forget the actual number of total RCPI debt) that would be required to get common shareholders to realize a penny. Hate to be a pessimist, but will only put a few extra $s into the pockets of the criminal creditors who struck the financing deal in the first place.

Maybe a rounding error just on the change they picked up in their smoking break room

Wasn't it Reynolds that "settled" with CIGX...the former RCPI so many years ago? Maybe this is play for leverage for PM vs. Reynolds.

Unfortunately, I am unaware of other accredited investors who have/had a stake in RCPI. You may be right on the value of the patents to P Morris. That said, it might simply be that the 235K is simply a "rounding error" to them that is worth more than the legal costs of fighting someone who might otherwise own the patents. That doesn't necessarily imply the patents are worth billions...only that lawyers would likely cost them more than 235K to defend/litigate.

Nep, I like your spunk! Put me in the category of one who used to be more accredited than I am today!

My ability/willingness to invest further very limited. That said, I would do anything possible to assist in any other way. Fear is that this may end up being a rat hole. My guess is that Phillip Morris may be willing to invest significantly more if they had to...but without more to go on this is a stab in the dark. Is it too late? Does PM get to come back with higher bid? Lots of questions.

...and his Press Releases read more like plaudits to employees at an office Christmas party. Where is any real revenue?...just alot of back slapping for vague partnership announcements. Usually, a good indication of a heavy dose of BS.

Correct. Unfortunately, knowledge of courts/legal processes are beyond most individual investors, myself included. This is especially true when there are so many unanswered questions about the technology value, etc. - this IS and WAS a major failure on the part of RCPI management. With all the contacts and conferences they were supposedly developing over the past 3 years (all post Jonnie W excuses that they regularly referenced), they were not able to generate enough interest by anyone other than Phillip Morris to buy IP at 235K? Shameful.

And look what's in today edition of USA Today on Phillip Morris!

https://www.usatoday.com/story/money/business/2018/01/03/philip-morris-marlboro-wants-give-up-cigarettes-go-smoke-free/1001442001/

And they are buying the IP for less than many of us lost individually on this "investment"!

For anyone interested in chasing the next big thing...

http://newyork.cbslocal.com/2018/01/02/alzheimers-treatment-diabetes/

Looks like they officially stick a fork in us on January 12.

Notice of Hearing Notice of Motion Pursuant to Sections 105(a) and 363 of the Bankruptcy Code and Bankruptcy Rules 2002, 6004, and 9014, (I) Authorizing the Sale of Intellectual Property Free and Clear of Liens, Claims and Encumbrances, and Other Interests, and (II) Granting Related Relief (related document(s)[21], [65]) Filed by George L. Miller. Hearing scheduled for 1/12/2018 at 09:30 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #3, Wilmington, Delaware. Objections due by 1/9/2018. (related document(s)[26], [26], [65]) (Richenderfer, Linda)

When RCPI is bankrupt I assume this message board goes away? If so, I believe those who are interested should at least have a way to correspond/communicate to 1) monitor what ultimately happens to IP and 2) to ensure that former directors/executives don't get away with prospering off said IP. Again, IMO, if they are allowed to do so, would certainly raise the prospect that they were never acting in the interest of shareholders.

For now, I will give former RCPI management the benefit of the doubt. BUT...I always found it a bit disturbing that Mullan maintained his separate role as CEO of Archer as well as a position with Roskamp Institute while CEO of RCPI. A case could likely be made that his decision-making and focus were in conflict with interests of shareholders. I also find it a bit concerning that Jenkins is now on BOD of Archer. I have no idea what Archer does/did other than being Mullan's way to cash in on the Nivaldipine study in Europe which turned out to be a loser. All of this said, in NO WAY should these guys be allowed to prosper with ANY of the IP/assets of the soon to be former RCPI. Their management of the company was incompetent at best...especially in the area of financing. Perhaps they are/were all hiding something and would prefer to simply have us "go away".

The interview with Hancock that I mentioned. From June of this year so perhaps things have changed even more to the positive since. He references 2.5-3M in revenue in 2018 near end of interview. Some confusion though as to whether he was referring to by 2018 vs. for whole of 2018. Your take?

https://upticknewswire.com/featured-interview-ceo-jim-hancock-of-global-payout-inc-otcpink-gohe/

There is an interview with current CEO out on their web site (sounds like perhaps he is giving up his position next week guessing from recent PR). Anyway, he projects revenue of 2-3M in 2018...it's a start...but certainly not much. Surprisingly little amount of solid information posted on this board!...mostly just roll the dice.

Email received today from IDCC:

Not One, But TWO 5G Webinars Available to Watch Now!
In the last couple months, InterDigital has participated in some ground-breaking conversations revolving around the future of 5G. As we gear up for 2018, be sure to check out one or both of these panels, whose topics range from IMT-2020 submissions to network slicing and NFV/SDN. Read more in the descriptions below, and download today!

"IEEE ComSoc: Converging Toward IMT-2020 Submissions"

The path to 5G standardization is a long one with a very busy and tight schedule. Several milestones towards IMT-2020 submission have been reached in various standards organizations. After releasing the IMT-2020 requirements document earlier in February, the ITU-R WP5D group has delivered the IMT-2020 evaluation document in June, setting the stage for standards organizations to propose and submit radio interface technologies for evaluation.

In this webinar, originally aired on Thursday, October 20, experts shed light on the complex standardization and evaluation process for IMT-2020 and provide updates on the latest status following the ITU-R workshop on IMT-2020 terrestrial radio interfaces that took place on Oct. 4th in Munich, Germany. Panelists include:
• Benoit Pelletier, InterDigital
• Ven Sampath, Ericsson Canada
• Ahmed Alsohaily, University of Toronto
• Giovanni Romano, Telecom Italia


"RCR Wireless: Network Slicing the Key that Unlocks 5G Revenue Potential - Where 5G Meets SDN/NFV"

End-to-end network slicing holds promise as the key to unlocking new business opportunities with 5G to drive revenue growth. So exactly how will service providers benefit from slicing? And how can they overcome technical challenges?

This webinar, developed by Strategy Analytics, showcases where business issues meet technical topics to help service providers uncover the opportunities and deliver on the promise of 5G with network slicing. Key topics explored include:
• What should operators and vendors do in 2017-2018 to prepare for 5G end-to-end (E2E) network slicing?
• What use cases, ecosystem players and business models can drive new revenues with network slicing?
• What business benefits beyond revenue growth can operators achieve with slicing?
• What are the right KPIs for measuring and guaranteeing network slices?
• Is network slicing essential for SDN enabled services?
• What is needed to make E2E slicing a reality? And where are the gaps?
In addition, Strategy Analytics highlights early examples of software defined network (SDN) enabled slices for SD-WAN QoS and Security, as well as leading vendor and service provider activities to date.

The webinar aims to cut through the hype and to provide a set of recommendations for service providers and their vendors. It focuses on near-to-mid-term activities to position players to maximize both near and longer term 5G opportunities.

Presenters:
• Susan Welsh de Grimaldo, Director, Strategy Analytics
• Sue Rudd, Director Service Provider Analysis, Strategy Analytics
• Maria Cuevas, Head of Mobile Core Network Research, BT
• Akbar Rahman, Senior Principal Engineer, InterDigital

SAN DIEGO, Dec. 27, 2017 (GLOBE NEWSWIRE) -- via OTC PR Wire -- Global Payout, Inc. (OTCPink:GOHE) ("Global, the Company") is pleased to provide its valued shareholders and interested parties with the following 2017 year-end letter of review from the Company's CEO, James H.:

Dear Valued Shareholders and Interested Parties:

For those of you who may have been following our news and updates throughout the year, you know 2017 has been an especially active, yet successful year for both Global Payout and our majority owned subsidiary, MoneyTrac Technology, Inc.

In January, my executive team and I laid-out a detailed list of objectives we believed were imperative to achieve in 2017 in order for the Company to position itself to drive revenue and truly distinguish the brand from all competitors in the Fintech market space. In reflecting upon the year that was, I can not only report with that we successfully achieved our objectives, but, we have surpassed them in ways I could not have imagined.

Without question, one of the most critical events of the year involved the appointment of Ms. Vanessa Luna as Global's Chief Operating Officer. Ms. Luna's experience and tenacity made an immediate impact within our Company's internal operations as she began to map out the path our Company would need to achieve each of our objectives.

Recognizing the gap between adequate financial technology solutions and the rapidly expanding, multi-billion-dollar cannabis industry, a collective decision was made in March to spinout our majority owned subsidiary, MoneyTrac Technology to begin serving the underserved businesses of the cannabis industry. With this spinout, Ms. Luna was transitioned over to MoneyTrac to serve as COO and to help spearhead the development of the brand by leveraging the many different strategic partnerships she had already developed within the industry.

Once given the green light, Ms. Luna was off to the races, cultivating several new, and incredibly significant partnerships for MoneyTrac. These partnerships include greenRush, BlazeNow, High Grade Management Group, and PotSaver, with whom she facilitated a majority acquisition in October. These partnerships, combined with several other important developments throughout the year, have effectively positioned MoneyTrac to generate revenue and become a recognized leader of a variety of service and solution offerings within the cannabis industry.

Significant groundwork was also laid in 2017 to support the growth and expansion of our logistics division. This includes critical enhancements made to our Global Reserve Platform that will serve as the foundation for a new logistics-focused subsidiary. An impressive executive team will lead this subsidiary in 2018 to carve-out a distinctive niche within the trillion-dollar logistics industry.

Focus during the 4th quarter of the year was also placed on positioning the Company to successfully complete its Form 10-K Audit. I cannot express how much gratitude I have for our internal operations team, who have worked so diligently over the past several weeks to see this through. I am highly optimistic that this will be completed in the coming weeks and will provide us with an opportunity to be up-listed to other platforms offered by the OTC Markets Group, such as the OTCQB and OTCQX.

The coming weeks will also be filled with some strategic changes and updates that will play a very important role in helping to shape the Company and its subsidiaries to meet future objectives. It is with great pleasure and excitement that I share that next week we anticipate announcing one of these changes, a passing of the baton that will be instrumental in guiding our Company's vision and objectives into a very prosperous future.

In closing, I would like to offer my sincerest thanks and appreciation to my wonderful team of executives and employees who are a shining example of hard work and dedication. I would also like to extend a special thank you to our valued shareholders who continue to demonstrate their loyalty and support. I can assure you, the best is very much yet to come.

Cheers to a very prosperous New Year!

Sincerely,

James L. H., CEO

About Global Payout, Inc. (OTC Pink:GOHE)

Since the Company's inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. In 2014, Global introduced its first online payment platform called the Consolidated Payment Gateway (CPG), which allowed its enterprise clients to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of its new, state of the art FINTECH payment system in 2017, for both online and mobile applications to allow account holders to maximize an expanded suite of financial services and minimize operational costs. Global will continue to offer their FINTECH payment system to many vertical markets for support of foreign currency exchange and digital currency, including ongoing support of the banking industry and international governments.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

Public Relations and Media Contact:

Global Payout

www.GlobalPayout.com

619.795.5810 Office

Information@GlobalPayout.com

Communications Contact:

NetworkNewsWire (NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com

Mine, agree with you...although I am not ready to jump to the conclusion that Mullan/Jenkins motives are completely nefarious. I will say that there is NO WAY that they should be allowed to bid on the IP without raising substantial conflict of interest given that they were both key to driving the company to Chapter 7. If common shareholders are left with nothing, then in no way should Archer/Mullan/Jenkins be allowed to in any way benefit from any past assets of RCPI. If so, I would say it would be worth bringing criminal charges against all involved. (may need a non-profit watchdog to fund such an initiative).

Bitcoin Plunges 25% in 24 Hours in a Cryptocurrency Market Rout

...this may not bode well for today's performance

er...news?...real news would be delivering on promises suggested in recent PRs to take place early in 2018 that would mean actual revenue. Hope it happens but won't be holding my breath.

Knuts, so are you suggesting that Jonnie needs some of the patent/IP currently assigned to RCPI?

I just think all worth keeping an eye on. Again, as long as Mullan is CEO of Archer and there is any connection with Roskamp, it warrants all of us with skin in the game with RCPI to keep following. Again, it would be unseemly for us to lose everything and have company leadership that was involved in RCPI make out in any way with assets (patents, work product, etc) that once belonged collectively to shareholders (unless they take us along for the ride).

Interesting. Ted Jenkins is now on Board of Directors of Archer Pharmaceuticals.

Why "absorb" Rock Creek if he is doing well with his new venture?

Very good point, of course! Their HQ lacks much resemblance to Bill Gates' garage from the 1970s that ultimately launched Msoft

Their PRs even have typos and questionable grammar. But hype is hype. I'll be a believer when they actually sell something.

My guess is that this is an effort to provide some "diversification" of GOHE being associated only with Cannabis, and more so, BitCoin. Note that PR references only Blockchain...which many analysts are saying is likely to be long term survivor regardless of what cryptocurrencies are the Winners. The real question, is GOHE really big/unique enough to have some traction in this space? Looks like they rely on outside developers for most all of their development.

Whatever keeps the "enthusiasm" to buy going...

Hmmm...similar conversations I've had with myself sitting in front of slot machines. Blockchain is the real story hear...and Bitcoin version of blockchain implementation might not be an ultimate winner since the "establishment" is very much against it. If GOHE has the flexibility to adopt other blockchain implementations alternatively, and quickly, may be a better future. I suspect as the cannabis business gets bigger and bigger, there will be increasing pressure to lift the regulatory constraints on the big banks and they will jump in and take over the market.

Might be interesting to put even an unrealistically low bid if for no other reason than being included in the process. 1manband to me has no reason to be here other than some nefarious interests...at least based on his constant refrain of Chapter 7 means death to all. Is he just a good guy giving us a continuous public service announcement?

Hate to agree with 1manband, but he is probably correct. If people really want to do something, they would post some information on what is required to bid on the assets. I am sure there is some legal process that must be followed...and who knows if that introduces bidders to some level of unanticipated risk. That said, if someone has the time and inclination to pursue all the details, I would be willing to throw in some $ for some kind of group bid. But that alone requires likely some legal agreement be created...everything involves lawyers and costs too much!

Maybe. My guess is that because the creditors would not work with them (RCPI)...and the RCPI management came to understand that they had been manipulated/screwed by the creditors/financing deal...that they decided to "get back" at them by going the bankruptcy route. What the RCPI former management gets out of this other than some "personal satisfaction" is TBD.

Knuts, not sure it's a question of "where ARE we going wrong" but more "where WERE we going wrong". My sense was that Mullan, Jenkins and company were too wet behind the ears in terms of establishing a realistic, achievable business strategy. Sure, they had lots of hurdles to overcome including the Jonnie Williams political news, past baggage from non-contributing BOD and leadership, etc. Ultimately, they were never able to convince a credible $ source that this company was worth the investment and that's all that eventually mattered. That is THEIR failure. I think they exacerbated the problem by hooking up with the death spiral financing. They would have been better off closing doors or at least suspending operations temporarily rather than the shady/naive financing approach that they took...it likely would have saved some of us considerable $.

As to why they couldn't convince others that the patent and technology is worth considerable $??? I can only assume that there may be other alternatives (as discussed here)...that may work as well or close to as well. Or, their patent(s) are simply not solid and/or protected enough. The other possibility of course is that the political clout of the FDA was too much to overcome...again, those politics can change...and had they not killed the company with the shady financing, perhaps we could have lived to fight another day.

I would have at least some trepidation about taking a neutraceutical that has not been really "vetted" like this Hydrapharm product. Also, to be frank, the "apparent" lack of interest in anatabine synthesis patent also makes me even wonder about the science backing Anatabine...or maybe it's just the value of the patent itself? I don't mean to overstate this, but I think in reality we need to consider all angles for why our investment in this company has failed.

It's almost 100% probable that all common shareholders are totally screwed here. Let's not use acronyms and mysterious guessing games if we have something to contribute/say. Why hide anything?...our best case for any satisfaction whatsoever (likely not monetary satisfaction) is calling out the truth.